Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in A lzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open‐label trial
Abstract Aim We investigated the clinical efficacy and changes in the dosages of concomitantly used psychotropic drugs in lamotrigine therapy in A lzheimer's disease with behavioural and psychological symptoms of dementia ( BPSD ). Methods This study was a 16‐week, preliminary open‐label trial....
Saved in:
Published in | Psychogeriatrics Vol. 15; no. 1; pp. 32 - 37 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
01.03.2015
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Aim
We investigated the clinical efficacy and changes in the dosages of concomitantly used psychotropic drugs in lamotrigine therapy in
A
lzheimer's disease with behavioural and psychological symptoms of dementia (
BPSD
).
Methods
This study was a 16‐week, preliminary open‐label trial. The subjects were 40 inpatients. The outcome measures assessed were
BPSD
and cognitive function.
BPSD
was assessed with the
N
europsychiatric
I
nventory (
NPI
) and cognitive function was assessed with the
M
ini‐
M
ental
S
tate
E
xamination. The changes in the dosages of concomitant psychotropic drugs were also assessed.
Results
Although the mean changes from baseline
NPI
scores and the two
NPI
subscales (anxiety and irritability) were significantly lower within the lamotrigine therapy group, no significant differences were found when we compared the lamotrigine therapy group to the control group. The mean decrease from baseline on the
NPI
agitation subscale, however, was significantly greater in the lamotrigine therapy group than in the control group (
P
< 0.05). Furthermore, the mean decrease from baseline in the diazepam‐equivalent dose was significantly greater in the lamotrigine therapy group than in the control group (
P
< 0.05).
Conclusions
The results of this study suggest that the administration of lamotrigine to patients with severe
A
lzheimer's disease with
BPSD
may be effective and may make it possible to avoid increasing the dosage of antipsychotic medications prescribed to elderly patients. |
---|---|
ISSN: | 1346-3500 1479-8301 |
DOI: | 10.1111/psyg.12085 |